Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-09
1998-08-25
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31495, A61K 3150
Patent
active
057983585
ABSTRACT:
An object of the invention is to provide an apoptosis regulating composition. According to the invention, an apoptosis regulating composition is provided which comprises, as an active ingredient, at least one carbostyril derivatives of general formula (1) ##STR1## and salts thereof.
REFERENCES:
patent: 4415572 (1983-11-01), Tominaga et al.
Sasayama et al, Heart and Vessels, 2(1):23-28 (1986).
Leuprasitsakul et al, Endocrinology, 128(6):2709-2714 (1991).
Berkow, The Merck Manual of Diagnosis and Therapy, 15th Ed., Merck Sharp & Dohme Research Laboratories, Rahway, N..J., pp. 1043-1050 (1987).
Bush et al, Experimental Hematology, 19(6):490 (1991).
Nakai et al, Biomedicine & Pharmacotherapy, 46(5-7):308 (1992).
Adachi Masakazu
Aihara Koutoku
Akamatsu Seiji
Ichikawa Hiroyuki
Mori Hitomi
Otsuka Pharmaceutical Co. Ltd.
Travers Russell
LandOfFree
Apoptosis regulating composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis regulating composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis regulating composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36512